Hosted on MSN1mon
Tenaya Therapeutics announces option repricing to retain staffAmid these developments, Tenaya announced the departure of Leone Patterson, its Chief Financial and Business Officer, and is currently seeking a replacement. Despite this, analyst firms such as H ...
As of December 31 cash, cash equivalents and investments in marketable securities were $61.4M compared to $104.6M as of December 31. With the ...
the granddaughter of Chief Tenaya and the last survivor of the expulsion of the Ahwahneechees in 1851. In 1930, he persuaded his superiors to let him and two colleagues conduct a four-year survey ...
Chief Executive Officer of Tenaya. “The recent financing with support from existing and new shareholders allows us to maintain our focus on driving our gene therapy programs for cardiomyopathies ...
Tenaya’s Chief Executive Officer, will participate in TD Cowen’s 45 th Annual Health Care Conference and the Leerink Partners Global Healthcare Conference 2025. Details are as follows ...
We look forward to sharing data from both the TN-201 MyPEAK-1 clinical trial for -associated ARVC in the months ahead,” said Faraz Ali, Chief Executive Officer of Tenaya. “The recent financing ...
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results